Rex Bionics REX

Powered hands-free exoskeleton for supervised rehab: self-supporting (no crutches/walker), leaving arms free for exercises. Movement generated by 10 custom linear actuators managed by 27 onboard microprocessors; suitable for users with reduced upper-limb strength.

Yes. Rex Bionics REX is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Rex Bionics REX is made by Rex Bionics, based in Auckland, New Zealand, founded in 2003.

4 verified deployments of Rex Bionics REX are on the DEPLOY registry, including at London, United Kingdom, Auckland, New Zealand, New Zealand, Oceania.

Rex Bionics REX is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

On the DEPLOY registry, comparable exoskeleton robots to Rex Bionics REX include Ant-H1 Pro, Cyberdyne HAL, German Bionic Cray X, HANK.

Rex Bionics REX and Ant-H1 Pro (Kenqing Technology · 5 deployments) are both exoskeleton robots on the DEPLOY registry. Rex Bionics REX has 4 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Rex Bionics REX ranks in roughly the top 32% of exoskeleton models tracked by the registry.

Rex Bionics REX is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Rex Bionics REX has 1 active incident on record in the DEPLOY registry. 1 incident on record (1 serious). Most recent: May 2016. Retracted incidents are excluded from this count.